Read the full deal writeup
Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.
Get Free AccessFull Editorial Writeup
Pharmacy business with two highly profitable business segments.... Businesses Franchises Brokers Loading... Established Pharmacy Services Group Ohio Asking Price:$18,000,000 Cash Flow (SDE):Not Disclosed EBITDA:$3,924,938 Gross Revenue:$12,336,209 Established:2001 Established Pharmacy Services Group Business Description Growing Pharmacy Platform Pharmacy business with two highly profitable business segments. Ad#:2532439 Detailed Information Inventory: $350,000Not included in asking price Facilities: All equipment and fixtures Reason for Selling: Retirement Business Location Real Estate: Leased Building SF: 9,000 Lease Expiration: 05/22/2029 Rent: $9,900 per month Listing Statistics Saved This Listing Listing Last Updated Appeared in Search Listing Detail Views BizBuySell EDGE Know the True Market Value Before You Make an Offer Get valuation data to negotiate with confidence. Get a Valuation Report Business Listed By: Richard Connley Ad#:2532439 The information in this listing has been provided by the business seller or representative stated above. BizBuySell has no stake in the sale of this business, has not independently verified any of the information about the business, and assumes no responsibility for its accuracy or completeness. Read BizBuySell's Terms of Use before responding to any ad. Learn how to avoid scams. Contact Form Full Name* Enter a valid Full Name Phone Number Enter Phone Number Email Address* Enter Email Address Optional Message Yes, send me the Buyer Newsletter for popular businesses, tips, & email promotions. Show sellers you’re serious - learn about BizBuySell Edge for premium buyer tools & alerts Send Message By clicking the button, you agree to BizBuySell’s Terms of Use and Privacy Notice Business Listed By: Richard Connley Your request has been sent. What Happens Next? is reviewing your details. A representative will reach out soon to discuss your options. Expect a response in 1-2 business days. Report an issue with this listing Similar Listings Pharmacies for Sale Home Health Care Businesses for Sale All Businesses for Sale in Ohio Innovative Nutraceutical Company with Patented, Science-Backed Product Hamilton County, OH Asking: $27,500,000 10 70+ Unit VIP Smoke Shop Portfolio | Tri-State Dominance | OH, KY, IN Cincinnati, OH Asking: $23,650,000 NNN Institutional Asset - 100% Bonus Depreciation Eligible Chillicothe, OH Asking: $26,400,000 HealthSource Chiropractic Franchise Opportunity In OH Cash Required: $150,000 ©2026 CoStar Group Send Message Listing Shared via Email a6301374279843840.cdn.optimizely.com a6301374279843840.cdn.optimizely.com is blocked This page has been blocked by an extension Try disabling your extensions. ERR_BLOCKED_BY_CLIENT Reload This page has been blocked by an extension Buy a Business Search for a Business Established Businesses Asset Sales How to Buy a Business Buy a Franchise Search Franchises For Sale Low Cost Franchises Restaurant and Food Franchises Business Opportunities Retail Franchises Sell a Business Sell a Business on BizBuySell Sell Multiple Businesses How to Sell a Business Value a Business Find a Broker Tools & Advice Learning Center Finance Center Market Insights Financial Benchmarks Business for Sale Blog Business Brokers Find a Broker For Brokers My BizBuySell Dashboard My Business Selling My Listings Guide to Selling Add a New Listing Searching My Saved Listings My Saved Searches Franchise Recommendations BizBuySell Edge Edge Preferences Recommendations Industry Benchmarks Location Insights BizBuySell Edge Edge Preferences Recommendations Industry Benchmarks Location Insights Research Guide to Buying Reports Message Center My Mailbox My Inquiries Email Preferences Export Leads Account Account Settings My Billing Info BrokerWorks My BizBuySell Dashboard Leads Billing My Saved Listings My Saved Searches Account Sign Out Sign In reCAPTCHA Recaptcha requires verification. protected by reCAPTCHA
Why we like it
- Earnings quality is the headline: $3.9M EBITDA on $12.3M revenue is a 31.8% margin, roughly 5x to 10x the margin of a typical retail pharmacy. That spread strongly implies the two segments live in higher-value niches (compounding, specialty, or long-term care) rather than commoditized retail dispensing, which is what justifies paying real money here.
- Pharmacy is about as recession-resistant as commerce gets. People fill prescriptions in every economic climate, most spend is insurance-reimbursed, and refill behavior is habitual, so demand does not evaporate in a downturn the way discretionary consumer or elective spend does.
- The business has operated since 2001, so 20-plus years of continuity means established payer contracts, DEA and state board licensing in good standing, referral relationships, and trained pharmacist staff. In a licensed, regulated field, that installed base is a genuine barrier to entry a new operator cannot replicate quickly.
- Two distinct segments provide diversification against single-line reimbursement or regulatory shocks. If one segment faces a reimbursement cut or a payer change, the other cushions the blow, which lowers the risk of a cliff-edge revenue event that plagues single-focus pharmacies.
How to improve it
- Nail down and separately model each of the two segments in the first 30 days: revenue, gross margin, payer mix, and customer concentration for each. You cannot optimize or defend what you do not understand, and the entire acquisition thesis depends on which segment is carrying the margin.
- Audit the payer and reimbursement mix and renegotiate or diversify away from any single PBM or plan that drives outsized volume. Reimbursement compression is the number one killer of pharmacy value, so building leverage and adding cash-pay or specialty lines protects the EBITDA you are paying 4.59x for.
- Lock down the pharmacist and technician team with retention agreements before close. In a licensed business, the pharmacist-in-charge and key staff are load-bearing, and losing them post-close could force a temporary shutdown of dispensing, so continuity here is non-negotiable.
- Address the 2029 lease well before you close by negotiating an extension or renewal option at the 9,000 square foot facility. A pharmacy is location- and license-tied, and a 2029 expiration with no visible option is a leverage point the landlord will exploit unless you fix it early.
- Pursue accretive add-ons in the higher-margin segment: expand compounding capacity, add specialty drug categories, or acquire book-of-business from retiring independent pharmacists nearby. Bolt-ons at low incremental cost are the fastest way to grow EBITDA on the existing license and facility.
- Build simple monthly reporting on script volume, margin per fill, and days-in-AR by payer. The seller likely ran this on instinct after 20 years, and installing basic operating dashboards will surface pricing and collection leaks that convert directly to cash flow.
Diligence notes
- Identify exactly what the two segments are and get audited or reviewed financials showing segment-level revenue and margin. The 31.8% EBITDA margin is exceptional for pharmacy, so verify it is real, sustainable, and not propped by one-time rebates, favorable reimbursement timing, or owner add-backs disguised as EBITDA.
- Scrutinize payer and customer concentration in each segment. If a single PBM contract, one long-term care facility, or a handful of prescribers drives most of the volume, the effective multiple is far higher than 4.59x because that revenue could walk after the seller retires.
- Verify all licensing, DEA registration, state board of pharmacy standing, and any specialty or compounding accreditations, and confirm they transfer or can be re-obtained cleanly under new ownership. Any open compliance issue, inspection deficiency, or controlled-substance audit flag can freeze operations.
- Confirm the reimbursement environment and any pending PBM rate changes or DIR fee dynamics affecting the segments. Pharmacy margins are exposed to policy and payer decisions outside the operator's control, so understand the forward reimbursement trend, not just trailing numbers.
- Review the lease terms in detail given the May 2029 expiration and the $9,900 monthly rent. Confirm renewal options, assignment rights on a sale, and whether the location itself (proximity to prescribers or facilities) is a driver of the business that must be preserved.
- Clarify the seller transition plan, since the reason for sale is retirement and no support offer is disclosed. Given the licensing and relationship-dependent nature of pharmacy, push for a meaningful handover period covering payer intros, prescriber relationships, and operational systems.
Source
Want the full analysis on every deal? Unlock the complete platform with Accredited Pro to screen live listings and read our operator-level writeups.